Siyang M. Liu
Guangdong Provincial Key Laboratory Of Translational Medicine In Lung Cancer
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Induction alectinib or crizotinib for stage III NSCLC harboring ALK fusion: A study with 4-year follow-up.
Journal: Chinese medical journal
Published: February 04, 2025
An Overview and Interpretation of Important Clinical Studies on Non-small Cell Lung Cancer in 2021
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: May 15, 2022
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.
Journal: Cancer immunology, immunotherapy : CII
Published: April 20, 2022
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial.
Journal: Clinical and translational medicine
Published: January 07, 2022
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005).
Journal: JTO clinical and research reports
Published: June 15, 2021
Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor.
Journal: International journal of biological sciences
Published: April 22, 2021
Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: August 02, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026